Pharm prime vendor fleet
Ended Awarded Last action
- Contract number
- SPE2DU26F0Q67
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,525
Award facts
- Contract value 100% obligated
- $1,524.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,524.82 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with a $499.999 billion ceiling, established on November 13, 2025, under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The award carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The delivery order is structured to provide pharmaceutical products and medical consumables to support Department of Defense healthcare operations, with an ultimate completion date of January 14, 2026.
DMS Pharmaceutical Group's product portfolio encompasses a comprehensive range of pharmaceuticals including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals. The PPV-G GEN V program, representing a $30.3 billion acquisition strategy, positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors supplying recurring medical needs to military healthcare facilities worldwide. The contractor's established federal contracting performance, demonstrated through numerous prior delivery orders funded by the DLA Medical Supply Chain division, supports its capability to fulfill the specialized pharmaceutical requirements of the military medical system. No subcontractors have been identified in the award documentation.
Quick answers
Who was awarded contract SPE2DU26F0Q67?
SPE2DU26F0Q67 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DU26F0Q67 worth?
The government has obligated $1,525 on SPE2DU26F0Q67.
Is contract SPE2DU26F0Q67 an order under another contract?
Yes. SPE2DU26F0Q67 is a delivery order under SPE2DU25D9811, an indefinite delivery contract.
Was contract SPE2DU26F0Q67 competed?
The extent of competition for SPE2DU26F0Q67 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award